WHITEPAPERS

In recent years, nitrosamine impurities have emerged as one of the most significant quality and safety challenges facing the global pharmaceutical industry.

Unlocking new frontiers in pharmaceutical innovation

What happens when a formulation that performs flawlessly in a 5-litre lab mixer is scaled up to a 500-litre production vessel—and <br>why is this delicate transition one of the most critical phases in pharmaceutical development that demands closer attention?